Study suggests breakthrough in organ transplants A small pilot study indicates that following up an imperfectly matched organ transplant with an infusion of the donor's stem cells may free recipients from a lifetime of anti-rejection drugs.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.